#Antiviral capsules suppliers in India

[kavyapharma]

Quality is not just the responsibility of Kavya Pharma’s quality team. This quality culture is embraced and promoted by every employee at Pharmaceutical suppliers in Gujarat, India. What matters most at the end of the day is the need of those patients for whom we manufacture these products.

[bigfandeer]

Global Antiviral Drugs Market 2021 | Global Opportunity Analysis and Industry Forecast, 2018-2022

Overview The anti-viral drugs market companies is anticipated to grow by US$62.67 by 2022 rapidly growing at a CAGR of 6.9% during the forecast period. The global anti-viral drugs market is driven by rise in healthcare expenditure and emergence of life-threatening diseases. These factors have helped shape the anti-viral drugs market and are expected to boost the growth. Companies in the anti-viral drugs market could also face challenges such as lack of awareness and shortage of skilled professionals. The details covered in the anti-viral drugs market report cover all the aspects of the industry. Anti-viral drugs market analysts have also shared growth projections in the report and have suggested anti-viral drugs market players to plan growth strategies accordingly.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2454

Segmentation

The global anti-viral drugs market has been segmented based on application and mechanism of action. By application, the market has been segmented into hepatitis, HIV/AIDS, herpes, influenza and others. By mechanism of action, the market has been segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, and others.

Regional Analysis

The Americas, Europe, Asia Pacific, and Middle East & Africa are the key markets for antiviral drugs. The Americas is the largest market followed by Europe. Growing prevalence of viral infections in the region, the presence of key players in the region and high healthcare expenditure drives the market in the Americas.

The Europe market is driven by the presence of a robust healthcare sector and high investment in R&D activities.

Asia Pacific is slated to be the fastest growing market for anti-viral drugs. Growing prevalence of viral infections in the developing economies of the region coupled with the outlay of massive amounts on healthcare facilities supports the growth of the Asia Pacific market.

Competitive Landscape

The anti-viral drugs market is supported by growing research and development investment. The population growth around the world and increasing demand of anti-viral drugs market based services and products also support the market growth. However, changes in policies and lack of clarity in guidelines can affect the market growth. The report covers all such details which will help companies in the anti-viral drugs market to strengthen their business plan and improve their product portfolio. The anti-viral drugs market research report also provides company profiles of major companies. The company profiles of many organizations operating in the anti-viral drugs market report highlights crucial details like company size, revenue growth, and details of mergers and acquisitions taking place in the anti-viral drugs market. New companies and established businesses can plan their strategies based on this data provided in the anti-viral drugs market research report.

Industry News

NeuroBo Pharmaceuticals, a biotechnology firm, has announced that it has purchased ANA Therapeutics, a privately owned biotechnology company that produces a patented niclosamide capsule formulation for the indication of coronavirus, now in Phase 2/3 clinical trials as a cure for COVID-19. The deal was unanimously approved by both the Boards of Directors of NeuroBo Pharmaceuticals and ANA Therapeutics

Table of Contents

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 Global Anti-Viral Drugs Market, by Application

5.1 Introduction

5.1.1 Hepatitis

5.1.2 HIV/AIDS

5.1.3 Herpes

5.1.4 Influenza

5.1.5 Others

Browse Complete Report @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half- Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

[pcdpharma19-blog]

India is Going to Become a Center for Covid-19 Antiviral Drugs

The drug controller issued emergency use authorization to pharmaceutical businesses in India to produce generic versions of molnupiravir.

After the drug controller issued emergency-use authorization to multiple pharmaceutical businesses in India to produce and commercialize generic versions of molnupiravir, India will become the world's largest hub for Covid-19 antiviral general medication production.

As Omicron infections develop in India, increased availability to molnupiravir will maintain hospitalizations and deaths to a manageable level.

Dr. Reddy's Laboratories, Torrent Pharmaceuticals, Cipla, Sun Pharma, Natco Pharma, Viatris, Hetero Drugs, and Mankind Pharma are among those who have received approval from the Drugs Controller General of India (DCGI).

Merck and Ridgeback Biotherapeutics developed Molnupiravir, the first ever oral antiviral medication for the treatment of severe individuals with mild to severe HIV infection. Covid-19.

Following the approval, many major pharmaceutical companies are planning to supply molnupiravir capsules in the upcoming days, with the remaining companies following the process.

As a result, India will become the world's largest producer of Covid-19 antiviral generic drugs. Molnupiravir's performance in the move-out phase III trial was promising, with a 50 % reduction in hospitalization in early-stage infections.

In India, the Covid-19 second wave peaked in April and May 2021, with daily average cases exceeding 4 lakh. Since then, caseloads have decreased dramatically, with the national total holding at just under 10,000 cases per day over the rest of the year.

However, the Omicron version, which is poised to supersede Delta as the prevalent variation, has caused an increase in daily Covid-19 cases in recent days.

According to the Union Health ministry, Covid-19 cases totaled 1,41,986 on January 8, 2022, with 3,071 of these cases verified as the Omicron variety.

Furthermore, India continues to fall short of its Covid-19 vaccination rollout target, with only 44.5 percent of the population having received the vaccine. As a result, given the slow vaccination rate and recent spike in Covid-19 cases, generic versions of molnupiravir may be able to dramatically lower.

Generic molnupiravir would improve access in India as well as other low- and middle-income nations (LMICs) while also removing present supply chain barriers.

In the United States, a 5 day treatment duration with molnupiravir costs roughly USD 712. (Rs 52,909). For a five-day course, generic versions of the medicine will costing between USD 18.79 (about Rs 1,400) and USD 21.48 (around Rs 1,600), which is much less.

We estimate molnupiravir generic versions to greatly expand availability in India as well as other LMICs after government approval because to their low cost.

Furthermore, as compared to Covid-19 intravenous antivirals like casirivimab/imdevimab or remdesivir, these oral antiviral medications will result in lower transport and distribution costs.

Oral medications do not require the use of glass vials because they are firm and compact, and the tablets can be closely packed without risk of breaking.

Similarly, a higher quantity of the medicine can be maintained within a given region, allowing the drug to be distributed at a faster rate.

Tag:-

Molnupiravir Capsules 200mg,

Molnupiravir available in India,

Molnupiravir manufacturers in India,

Molnupiravir capsules 200 mg price in India,

Molnova Capsules,

Molnova Capsule Manufacturer,

Molnova Capsule Supplier

[alliedmarketresearchs]

Moringa seeds Market Trends 2021 | Segmentation, Outlook, Industry Report to 2030

Moringa seeds are obtained from the pods of Moringa oleifera popularly known as drumstick tree, which is native to Northern India. Fresh and raw seeds are quite tender but as soon as they get dried, they become hard. Moringa is also regarded as a vegetable tree which full of minerals, vitamins, and is eaten as a healthy super food. It is known to have numerous health promoting benefits and is used to cure and prevent diseases. Moringa can be taken in various forms viz., raw, powdered and is used in food supplements, tea and oil. The market of these products is influenced by multiple factors like rise in need for nutritional supplements, which imparts health awareness among various sectors of society and shifting focus toward organic products in medication. It possesses antifungal, antiviral, antidepressant, and anti-inflammatory properties which helps to cure various diseases. It is regarded as one of the best products to treat severe malnutrition in children less than 3 years. Demand for Moringa has been on a perpetual rise, on account of the increase in advocacy of consumers toward a healthy lifestyle.

Market Scope and Structure Analysis

Ø  Market Size Available for Years

2020–2030

Ø  Base Year Considered

2020

Ø  Forecast Period

2021–2030

Ø  Forecast Unit

Value (USD)

Ø  Regions Covered

North America, Europe, Asia-Pacific, LAMEA

Ø  Segment Covered

Application, Product Type, Distribution Channel, and Region

Ø  Companies Covered

New Global Energy Inc., Green Earth Products Pvt. Ltd., Vyora Herbals Private Limited, Marudhar Impex, Paritosh Herbals, Philippine Moringa and More Corporation, Jailev International Trading Corporation, Tropical Palm Herb Manufacturing, Mother’s Farm, Genius Nature Herbs Private Limited, Kuli Kuli Foods, Earth Expo Company, Ancient Greenfields, and Grenera

Get a sample of the report @ https://www.alliedmarketresearch.com/request-sample/12376

COVID-19 Impact analysis

There     is an increase in demand for moringa seeds among people owing to rise in     health consciousness due to huge widespread of COVID-19.

However,     the fact cannot be neglected that the economies were shut down during the     spread of the COVID-19 across the globe, which led to shut down of the     various plants, factories, and sites, which resulted in the low production.

Lockdowns     across the globe in 2020 and continuing restrictions in 2021 disrupted the     supply chain posing challenges for manufactures in the moringa seeds     market. Intense competition, pricing issues, and shifting consumer     preferences continue to put pressure on vendors' profit margins.

Top Impacting Factors

The     customers need for staying healthy and fit is major growth driving factor     responsible for the growth of the moringa seeds market.

It     possesses antifungal, antiviral, antidepressant, and anti-inflammatory     properties which helps to cure various diseases. It is regarded as one of     the best products to treat severe malnutrition in children less than 3     years. This is another factor that drives the growth of the moringa seeds     market.

The     consumers are more inclined toward a healthy lifestyle. Thus, leading to     the growth of the market.

Market Trends

Moringa – A super food

Availability of moringa in various types of food products is anticipated to intensify the growth of the market. Manufacturers across the world have been focusing on offering it in various forms to make it easily consumable owing to increase in popularity of moringa as a superfood. Thus, most of the companies offer Moringa in powdered form, which can be added to the food products, to enhance its nutritional value. In addition, the rise in importance of breakfast is expected to create increased demand for Moringa as breakfast cereals, nutritional shakes, smoothies, soups, and snack bars.

There has been a significant rise in the demand for Moringa capsules attributed to increase in health supplements for the treatment of hair and skin related problems, detoxification, and offset stabilization of the insulin level in the body. As a result, easily consumable capsules are yet another concrete growth drivers for the growth of the global moringa market.

Asia-Pacific is the largest revenue contributor

Asia Pacific enjoys supremacy in the global moringa market since the trees are native to India. In the Asia Pacific region, India is the forerunning supplier of moringa oil, moringa leaf, moringa seeds, and moringa fruits, which further contributes toward the growing size of the moringa market.

Being protein-rich in nature, moringa has been utilized as a great substitute for meat. Rise in trends of veganism in American countries are paving the path for the plant-based food products, which is expected to create strong demand for moringa in the forthcoming years.

Request a discount on the report @ https://www.alliedmarketresearch.com/purchase-enquiry/12376

Application

Dietary     Supplements

Pharmaceuticals

Cosmetics

Product Type

Moringa     Seeds & Oil

Moringa     Leaves & Leaf Powder

Moringa     Fruits, Tea & Pods

Distribution Channel

Direct

Indirect

Region

North     America

o    U.S.

o    Canada

o    Mexico

Europe

o    Germany

o    France

o    UK

o    Spain

o    Italy

o    Rest of Europe

Asia-Pacific

o    China

o    India

o    Japan

o    Australia

o    South Korea

o    Rest of Asia-Pacific

LAMEA

o    Latin America

o    Middle East

o    Africa

Key Benefits of the Report

This     study presents the analytical depiction of the Moringa Seeds industry     along with the current trends and future estimations to determine the     imminent investment pockets.

The     report presents information related to key drivers, restraints, and     opportunities along with detailed analysis of the Moringa Seeds market     share.

The     current market is quantitatively analyzed from 2020 to 2028 to highlight     the XYZ market growth scenario.

Porter’s     five forces analysis illustrates the potency of buyers & suppliers in     the market.

The     report provides a detailed Moringa Seeds market analysis based on     competitive intensity and how the competition will take shape in coming     years

Questions answered in the Report

Who     are the leading market players active in the Moringa Seeds market?

What     current trends will influence the market in the next few years?

What     are the driving factors, restraints, and opportunities in the market?

What     future projections would help in taking further strategic steps?

What     is "Moringa seeds” Market prediction in the future?

Which     will be the niches at which players profiling with recent advancements     should set a presence?

What     are the driving factors and opportunities in the market?

What     are the current trends and predicted trends?

What     are the challenges faced in the "Moringa Seeds" Market?

To know more about the report @ https://www.alliedmarketresearch.com/moringa-seeds-market-A12011

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting services to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

[kavyapharma]

WE WELCOME YOU TO KAVYA PHARMA (we ensure healthy tomorrow) including API (Active Pharmaceutical Ingredients) and Intermediates (a leading manufacturer and supplier of WHO-GMP certified pharmaceutical products).

[pcdpharma19-blog]

India is Going to Become a Center for Covid-19 Antiviral Drugs

The drug controller issued emergency use authorization to pharmaceutical businesses in India to produce generic versions of molnupiravir.

After the drug controller issued emergency-use authorization to multiple pharmaceutical businesses in India to produce and commercialize generic versions of molnupiravir, India will become the world's largest hub for Covid-19 antiviral general medication production.

As Omicron infections develop in India, increased availability to molnupiravir will maintain hospitalizations and deaths to a manageable level.

Dr. Reddy's Laboratories, Torrent Pharmaceuticals, Cipla, Sun Pharma, Natco Pharma, Viatris, Hetero Drugs, and Mankind Pharma are among those who have received approval from the Drugs Controller General of India (DCGI).

Merck and Ridgeback Biotherapeutics developed Molnupiravir, the first ever oral antiviral medication for the treatment of severe individuals with mild to severe HIV infection. Covid-19.

Following the approval, many major pharmaceutical companies are planning to supply molnupiravir capsules in the upcoming days, with the remaining companies following the process.

As a result, India will become the world's largest producer of Covid-19 antiviral generic drugs. Molnupiravir's performance in the move-out phase III trial was promising, with a 50 % reduction in hospitalization in early-stage infections.

In India, the Covid-19 second wave peaked in April and May 2021, with daily average cases exceeding 4 lakh. Since then, caseloads have decreased dramatically, with the national total holding at just under 10,000 cases per day over the rest of the year.

However, the Omicron version, which is poised to supersede Delta as the prevalent variation, has caused an increase in daily Covid-19 cases in recent days.

According to the Union Health ministry, Covid-19 cases totaled 1,41,986 on January 8, 2022, with 3,071 of these cases verified as the Omicron variety.

Furthermore, India continues to fall short of its Covid-19 vaccination rollout target, with only 44.5 percent of the population having received the vaccine. As a result, given the slow vaccination rate and recent spike in Covid-19 cases, generic versions of molnupiravir may be able to dramatically lower.

Generic molnupiravir would improve access in India as well as other low- and middle-income nations (LMICs) while also removing present supply chain barriers.

In the United States, a 5 day treatment duration with molnupiravir costs roughly USD 712. (Rs 52,909). For a five-day course, generic versions of the medicine will costing between USD 18.79 (about Rs 1,400) and USD 21.48 (around Rs 1,600), which is much less.

We estimate molnupiravir generic versions to greatly expand availability in India as well as other LMICs after government approval because to their low cost.

Furthermore, as compared to Covid-19 intravenous antivirals like casirivimab/imdevimab or remdesivir, these oral antiviral medications will result in lower transport and distribution costs.

Oral medications do not require the use of glass vials because they are firm and compact, and the tablets can be closely packed without risk of breaking.

Similarly, a higher quantity of the medicine can be maintained within a given region, allowing the drug to be distributed at a faster rate.

Tag:-

Molnupiravir Capsules 200mg,

Molnupiravir available in India,

Molnupiravir manufacturers in India,

Molnupiravir capsules 200 mg price in India,

Molnova Capsules,

Molnova Capsule Manufacturer,

Molnova Capsule Supplier

[pcdpharma19-blog]

Molnupiravir Capsules 200 mg Supplier & Exporter in India

We are one of the leading Molnupiravir Capsules 200 mg supplier, manufacturer and exporter in India. Molnupiravir is effective & affordable antiviral medicine developed for the treatment of corona virus.It is a prodrug of the synthetic nucleoside derivative N4- hydroxycytidine that inhibits viral RNA replication by preventing copying mistakes.

[pcdpharma19-blog]

We are one of the leading molnupiravir capsules 200mg supplier and exporter in India. Molnupiravir capsule is one of the effective antiviral medicine developed for the effective treatment of corona virus. It is well researched and proved safe and effective for corona. Our offered molnupiravir capsule is available at affordable prices.

[pcdpharma19-blog]

Molnupiravir capsules 200mg Supplier & Exporter - Molnova

We are one of the leading molnupiravir capsules 200mg supplier and exporter in India. Molnupiravir capsule is one of the effective antiviral medicine developed for the effective treatment of corona virus. It is well researched and proved safe and effective for corona. Our offered molnupiravir capsule is available at affordable prices.